InnovationFlow è un progetto di
CIC-39: A Novel Promising Small Molecule For The Treatment Of Tubular Aggregate Myopathies and Duchenne Muscular Dystrophy Predictive kit to identify patients not responding to platinum therapy Therapeutic agent delivery system based on Adipose Stromal/Stem Cells
CIC-39: A Novel Promising Small Molecule For The Treatment Of Tubular Aggregate Myopathies and Duchenne Muscular Dystrophy
Predictive kit to identify patients not responding to platinum therapy
Therapeutic agent delivery system based on Adipose Stromal/Stem Cells
InnovationFlow è un progetto di